Kenvue Inc. (NYSE:KVUE) Shares Bought by Richard C. Young & CO. LTD.

Richard C. Young & CO. LTD. lifted its position in shares of Kenvue Inc. (NYSE:KVUE) by 1.2% during the third quarter, Holdings Channel reports. The firm owned 372,388 shares of the company’s stock after acquiring an additional 4,322 shares during the quarter. Richard C. Young & CO. LTD.’s holdings in Kenvue were worth $8,613,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Kingsview Wealth Management LLC purchased a new stake in Kenvue in the 1st quarter valued at $253,000. Covestor Ltd purchased a new position in shares of Kenvue during the first quarter worth about $109,000. Ameritas Investment Partners Inc. increased its position in Kenvue by 1.7% in the 1st quarter. Ameritas Investment Partners Inc. now owns 136,775 shares of the company’s stock valued at $2,935,000 after acquiring an additional 2,321 shares during the period. O Shaughnessy Asset Management LLC raised its stake in Kenvue by 34.3% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 30,765 shares of the company’s stock valued at $660,000 after acquiring an additional 7,854 shares during the last quarter. Finally, Clearbridge Investments LLC lifted its position in Kenvue by 16,051.1% during the 1st quarter. Clearbridge Investments LLC now owns 9,813,597 shares of the company’s stock worth $210,600,000 after acquiring an additional 9,752,836 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

KVUE has been the topic of a number of recent research reports. UBS Group boosted their target price on Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Wednesday, August 7th. Bank of America boosted their price objective on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Tuesday, October 22nd. Piper Sandler raised their target price on shares of Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Monday, September 23rd. Jefferies Financial Group initiated coverage on shares of Kenvue in a research note on Tuesday, September 24th. They set a “buy” rating and a $27.00 price target on the stock. Finally, Royal Bank of Canada downgraded shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective for the company. in a research report on Tuesday, September 24th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and an average target price of $22.64.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $23.82 on Monday. The firm has a market capitalization of $45.67 billion, a price-to-earnings ratio of 43.31, a price-to-earnings-growth ratio of 2.16 and a beta of 1.36. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The business’s 50 day simple moving average is $22.77 and its 200-day simple moving average is $20.70. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.13.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, November 7th. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. The company had revenue of $3.90 billion for the quarter, compared to the consensus estimate of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. Kenvue’s quarterly revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.31 earnings per share. As a group, equities analysts forecast that Kenvue Inc. will post 1.07 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be issued a dividend of $0.205 per share. The ex-dividend date is Wednesday, November 13th. This represents a $0.82 annualized dividend and a yield of 3.44%. Kenvue’s dividend payout ratio (DPR) is currently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.